HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maurizio Sanguinetti Selected Research

SARS-CoV-2 envelope protein

11/2020Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis.
5/2020Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maurizio Sanguinetti Research Topics

Disease

75Infections
08/2022 - 01/2002
26COVID-19
08/2022 - 05/2020
22Sepsis (Septicemia)
08/2021 - 09/2003
12Candidiasis (Moniliasis)
12/2022 - 03/2008
10Neoplasms (Cancer)
01/2022 - 07/2006
10Mycoses (Diseases, Fungus)
06/2021 - 12/2011
9Tuberculosis (Tuberculoses)
05/2021 - 05/2006
8Clostridium Infections
07/2021 - 05/2014
8Aspergillosis
11/2019 - 12/2011
7Candidemia
10/2020 - 06/2007
6Inflammation (Inflammations)
01/2020 - 02/2009
5Pneumonia (Pneumonitis)
12/2021 - 06/2016
5Invasive Candidiasis
06/2021 - 01/2010
5Critical Illness (Critically Ill)
01/2021 - 09/2017
5Communicable Diseases (Infectious Diseases)
07/2020 - 01/2015
5Invasive Fungal Infections
12/2019 - 12/2012
4Bacteremia
01/2021 - 04/2004
4Urinary Tract Infections (Urinary Tract Infection)
10/2017 - 09/2010
3Fibrosis (Cirrhosis)
01/2022 - 12/2018
3Bacterial Infections (Bacterial Infection)
01/2021 - 12/2014
3Septic Shock (Toxic Shock Syndrome)
09/2020 - 09/2015
3Coinfection
09/2020 - 05/2016
3Cryptococcosis
12/2018 - 01/2003
3Fusariosis
12/2012 - 12/2011
2Dyspnea (Shortness of Breath)
04/2022 - 11/2021
2Cystic Fibrosis (Mucoviscidosis)
01/2022 - 01/2019
2Dysbiosis
01/2022 - 05/2020
2Glioblastoma (Glioblastoma Multiforme)
11/2021 - 06/2019
2Keratitis
01/2021 - 07/2015
2Virus Diseases (Viral Diseases)
01/2021 - 05/2016
2Viremia
10/2020 - 01/2020
2Necrosis
01/2020 - 12/2018
2Vaginitis
11/2019 - 01/2019
2Vulvovaginal Candidiasis
11/2019 - 01/2014
2Colitis
03/2019 - 04/2014
2Central Nervous System Infections (Central Nervous System Infection)
06/2016 - 08/2008

Drug/Important Bio-Agent (IBA)

18Anti-Bacterial Agents (Antibiotics)IBA
08/2022 - 02/2004
16Pharmaceutical PreparationsIBA
12/2022 - 03/2008
12AzolesIBA
01/2020 - 02/2005
8AntigensIBA
05/2022 - 08/2003
8Fluconazole (Zonal)FDA LinkGeneric
09/2020 - 01/2003
7AntibodiesIBA
05/2022 - 01/2010
6Interleukin-6 (Interleukin 6)IBA
05/2022 - 09/2007
6EchinocandinsIBA
06/2021 - 11/2010
5RNA (Ribonucleic Acid)IBA
07/2021 - 01/2015
5galactomannanIBA
11/2019 - 08/2003
5VancomycinFDA LinkGeneric
01/2018 - 01/2012
4Messenger RNA (mRNA)IBA
08/2022 - 06/2006
4CytokinesIBA
05/2022 - 12/2018
4C-Reactive ProteinIBA
04/2022 - 02/2009
4Peptides (Polypeptides)IBA
02/2022 - 12/2011
4Immunoglobulin G (IgG)IBA
01/2022 - 01/2014
4graphene oxideIBA
07/2021 - 12/2016
4Voriconazole (Vfend)FDA LinkGeneric
01/2021 - 07/2007
416S Ribosomal RNAIBA
05/2020 - 07/2006
4Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2006
4EnzymesIBA
10/2017 - 08/2003
4DNA (Deoxyribonucleic Acid)IBA
06/2016 - 02/2009
4Antifungal AgentsIBA
07/2015 - 08/2006
4Amphotericin B (Amphotericin)FDA LinkGeneric
11/2013 - 08/2006
4Caspofungin (Cancidas)FDA Link
04/2013 - 08/2006
4beta-Lactamases (beta-Lactamase)IBA
09/2008 - 02/2004
4CoagulaseIBA
08/2008 - 09/2003
3SodiumIBA
10/2021 - 04/2014
3Carbapenems (Carbapenem Antibiotics)IBA
08/2021 - 01/2020
3polyglucosanIBA
06/2021 - 09/2017
3Antiviral Agents (Antivirals)IBA
10/2020 - 12/2018
3Biological ProductsIBA
05/2020 - 03/2006
3Biomarkers (Surrogate Marker)IBA
01/2020 - 09/2017
3Valacyclovir (Valtrex)FDA LinkGeneric
01/2020 - 11/2019
3ATP-Binding Cassette Transporters (ABC Transporters)IBA
06/2019 - 09/2010
3liposomal amphotericin BFDA Link
03/2019 - 05/2012
3MannansIBA
01/2019 - 01/2010
2Volatile Oils (Essential Oils)IBA
12/2022 - 05/2020
2fibrin fragment D (D-dimer)IBA
04/2022 - 11/2021
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2022 - 01/2019
2Phosphatidylinositols (Phosphatidylinositol)IBA
12/2021 - 07/2006
2Therapeutic UsesIBA
11/2021 - 05/2020
2Isoniazid (Ftivazide)FDA LinkGeneric
05/2021 - 07/2020
2TriazolesIBA
02/2021 - 05/2011
2Proton Pump InhibitorsIBA
01/2021 - 11/2016
2SARS-CoV-2 envelope proteinIBA
11/2020 - 05/2020
2LipopolysaccharidesIBA
01/2020 - 12/2018
2GlucansIBA
01/2020 - 01/2019
2EndotoxinsIBA
01/2020 - 12/2018
2GoldIBA
01/2020 - 01/2015
2DisaccharidesIBA
12/2019 - 01/2019
2fenticonazoleIBA
11/2019 - 01/2019
2Dextrans (Dextran)FDA Link
03/2019 - 04/2014
2carbapenemaseIBA
04/2017 - 07/2014
2Complement System Proteins (Complement)IBA
01/2017 - 09/2006

Therapy/Procedure

51Therapeutics
08/2022 - 01/2002
8Central Venous Catheters
03/2019 - 06/2007
7Lasers (Laser)
02/2022 - 05/2014
6Fecal Microbiota Transplantation
05/2022 - 01/2019
6Transplantation
07/2021 - 05/2014
2Artificial Respiration (Mechanical Ventilation)
01/2021 - 01/2020
2Length of Stay
10/2020 - 11/2019
2Critical Care (Surgical Intensive Care)
01/2019 - 09/2017
2Catheters
01/2019 - 01/2015